Microbot Medical (MBOT)
(Delayed Data from NSDQ)
$0.88 USD
+0.02 (1.95%)
Updated Apr 26, 2024 03:54 PM ET
After-Market: $0.88 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth C Momentum B VGM
Cash flow Statements
Fiscal Year End for Microbot Medical Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -10.74 | -13.17 | -11.31 | -9.17 | -7.25 |
Depreciation/Amortization & Depletion | 0.11 | 0.10 | 0.08 | 0.07 | 0.08 |
Net Change from Assets/Liabilities | -0.01 | -0.23 | 0.50 | -0.02 | -0.27 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 2.11 | 1.75 | 1.39 | 1.88 | 0.98 |
Net Cash From Operating Activities | -8.53 | -11.55 | -9.35 | -7.25 | -6.45 |
Property & Equipment | -0.03 | -0.08 | -0.07 | -0.09 | 0.04 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 2.01 | -3.75 | 3.27 | -2.68 | -2.50 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 1.97 | -3.84 | 3.20 | -2.77 | -2.45 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 6.56 | 4.32 | 0.00 | 0.00 | 36.77 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | -3.38 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 6.56 | 4.32 | 0.00 | -3.38 | 36.77 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 0.00 | -11.06 | -6.15 | -13.40 | 27.87 |
Cash at Beginning of Period | 2.52 | 13.58 | 19.73 | 33.13 | 5.26 |
Cash at End of Period | 2.52 | 2.52 | 13.58 | 19.73 | 33.13 |
Diluted Net EPS | -1.05 | -1.81 | -1.59 | -1.29 | -1.70 |
Fiscal Year End for Microbot Medical Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -10.74 | -7.59 | -5.14 | -2.85 |
Depreciation/Amortization & Depletion | NA | 0.11 | 0.07 | 0.05 | 0.03 |
Net Change from Assets/Liabilities | NA | -0.01 | -0.19 | -0.69 | -0.76 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 2.11 | 0.99 | 0.73 | 0.39 |
Net Cash From Operating Activities | NA | -8.53 | -6.71 | -5.06 | -3.20 |
Property & Equipment | NA | -0.03 | -0.04 | -0.01 | 0.00 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 2.01 | -0.95 | 1.60 | 2.88 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 1.97 | -0.98 | 1.59 | 2.88 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 6.56 | 6.56 | 6.72 | 0.00 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 6.56 | 6.56 | 6.72 | 0.00 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | 0.00 | -1.14 | 3.25 | -0.32 |
Cash at Beginning of Period | NA | 2.52 | 2.52 | 2.52 | 2.52 |
Cash at End of Period | NA | 2.52 | 1.38 | 5.77 | 2.20 |
Diluted Net EPS | NA | -0.23 | -0.21 | -0.25 | -0.36 |